Choose 65782 for an autologous graft taken from the patient. Use 65781 when the limbal stem cell graft comes from a donor.
On this page
CMS RVU26D · Effective 2026-10-01
65782 Ocular reconstruction Medicare reimbursement rates in New Jersey
Reports ocular surface reconstruction using the patient's own limbal stem cells, typically for severe limbal stem cell deficiency after ocular surface injury. Compare 65782 office and facility rates across CMS payment localities in New Jersey.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 65782 in New Jersey?
New Jersey has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
Office / nonfacility
No supported rate
Facility setting
$1037.29–$1076.97
2 of 2 localities have a supported rate.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Ophthalmic surgery
About 65782: Ocular surface reconstruction with autologous limbal graft
Reports ocular surface reconstruction using the patient's own limbal stem cells, typically for severe limbal stem cell deficiency after ocular surface injury.
An ophthalmic surgeon transplants limbal stem cells taken from the patient to rebuild a damaged ocular surface. This is used for limbal stem cell deficiency, often after a chemical or thermal injury, when the patient’s own viable limbal tissue can serve as the graft source. The operation is typically performed in a surgical facility by a cornea or ocular-surface specialist.
Report 65782 when the reconstruction uses the patient’s own limbal tissue; an allograft from a donor is a different code in this family. The operative record should identify the recipient eye, the autologous tissue source, and the transplant performed. CMS assigns a 90-day global period, including the day-before preoperative visit and related postoperative care. For multiple procedures in one session, the highest-valued procedure is paid in full and other procedures are subject to the standard 50% reduction. Modifier 50 identifies bilateral surgery, paid at 150%. Assistant-at-surgery payment is restricted; co-surgeon payment requires supporting documentation, and team surgery is not permitted.
CMS billing rules for 65782
- Global period
- Major surgery with a 90-day global period: the day-before preoperative visit and 90 days of related postoperative care are included.
- Multiple procedures
- Standard multiple procedure reduction: the highest-valued procedure is paid in full and others at 50% when performed in the same session.
- Bilateral procedures
- Bilateral procedure with modifier 50 is paid at 150%.
- Assistant at surgery
- Statutory restriction: assistant at surgery is not paid.
- Co-surgeons
- Co-surgeons paid only with supporting documentation.
- Team surgery
- Team surgery not permitted.
Where the value comes from
- Work RVU15.04 · 52%
- Practice expense (office) RVU12.90 · 44%
- Malpractice RVU1.21 · 4%
385
Medicare services in 2024 · #3769 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
65782 compared with similar codes
Office rates for New Jersey, from the same CMS release.
65780 describes ocular surface reconstruction using amniotic membrane transplantation. 65782 is distinguished by transplantation of the patient's own limbal stem cells.
65778 is amniotic membrane placement without sutures, not autologous limbal stem cell transplantation.
65779 is amniotic membrane placement with sutures. It does not represent reconstruction using the patient's own limbal stem cells.
Compare 65782 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Northern Nj →
Office / nonfacility
Unavailable
Facility
$1076.97
Rest Of New Jersey →
Office / nonfacility
Unavailable
Facility
$1037.29
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
65782 billing questions
How does 65782 differ from 65781?
65782 is for limbal stem cells taken from the patient; 65781 is for an allograft from a donor. Document the graft source.
Does 65782 include harvesting the patient's tissue?
The autograft procedure involves obtaining the patient's own limbal tissue and transplanting it to reconstruct the ocular surface. Document the source and transplant.
When would 65778 or 65779 be considered instead?
Those codes describe amniotic membrane placement on the ocular surface, without or with sutures, rather than reconstruction using an autologous limbal stem cell graft.
What is included in the 90-day global period?
The day-before preoperative visit and 90 days of related postoperative care are included in the global period.
How is bilateral 65782 reported?
Use modifier 50 for bilateral surgery; CMS pays the bilateral procedure at 150%.
Can an assistant or co-surgeon be reported?
CMS restricts assistant-at-surgery payment for this code. Co-surgeon payment requires supporting documentation, and team surgery is not permitted.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
